Nasdaq
LENZ
LENZ Therapeutics, Inc.
- Health Care
- Listed 2021
- 1 day
- −0.9%
- 1 month
- −11.5%
- 1 year
- −82.7%
$5.22 · Mkt cap $164M
At the 6 Aug 2026 close
Nasdaq
LENZ Therapeutics, Inc.
$5.22 · Mkt cap $164M
At the 6 Aug 2026 close
LENZ Therapeutics, Inc. trades under the ticker LENZ on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2021. Its market capitalisation is $164M. The last closing price was $5.22, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −82.7%, and −11.5% over the past month. Returns are price returns and exclude dividends.
This page exists because LENZ is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.